Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options
Top Cited Papers
- 1 June 2011
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (16), e473-e476
- https://doi.org/10.1200/jco.2010.32.8351
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Major and minor salivary gland tumorsCritical Reviews in Oncology/Hematology, 2010
- Systemic Therapy in the Palliative Management of Advanced Salivary Gland CancersJournal of Clinical Oncology, 2006
- Clinical and immunohistologic typing of salivary duct carcinomaCancer, 2005
- Salivary duct carcinomaCancer, 2001
- Salivary duct carcinoma: Clinical characteristics and treatment strategiesHead & Neck, 1997
- Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinomaAnnals of Oncology, 1996
- Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patientsCancer, 1991
- WHO International Histological Classification of Tumours Tentative Histological Classification of Salivary Gland TumoursPathology - Research and Practice, 1990
- Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland originCancer, 1987
- SpeichelgangcarcinomeEuropean Archives of Oto-Rhino-Laryngology, 1968